ACA
RMD icon

Aptus Capital Advisors’s ResMed RMD Stock Holding History

Aptus Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,216
Closed -$293K – 1770
2025
Q4 		$293K Buy
1,216
+9
+0.7% +$2.3K ﹤0.01% 894
2025
Q3 		$330K Sell
1,207
-19
-2% -$5.19K ﹤0.01% 816
2025
Q2 		$316K Sell
1,226
-7
-0.6% -$1.67K ﹤0.01% 806
2025
Q1 		$276K Sell
1,233
-270
-18% -$63K ﹤0.01% 794
2024
Q4 		$344K Buy
+1,503
New +$362K ﹤0.01% 738
2021
Q3 		– Sell
-11,721
Closed -$2.89M – 597
2021
Q2 		$2.89M Sell
11,721
-274
-2% -$57.6K 0.08% 118
2021
Q1 		$2.33M Sell
11,995
-1,336
-10% -$268K 0.08% 116
2020
Q4 		$2.83M Sell
13,331
-256
-2% -$51K 0.13% 98
2020
Q3 		$2.33M Buy
13,587
+429
+3% +$79.2K 0.12% 107
2020
Q2 		$2.53M Buy
+13,158
New +$2.15M 0.16% 92

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Aptus Capital Advisors's RMD Position: Q1 2026 in Review

Aptus Capital Advisors sold out of ResMed (RMD) in Q1 2026, closing a stake of 1,216 shares — an estimated $293K sold.

Aptus Capital Advisors first reported a position in RMD in Q2 2020 and held it in 10 quarters. The position peaked at $2.89M in Q2 2021. 945 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Aptus Capital Advisors reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Aptus Capital Advisors sold 1,216 ResMed shares in Q1 2026, an estimated $293K.
  • Aptus Capital Advisors first reported a position in ResMed in Q2 2020 and held it in 10 quarters.
  • Aptus Capital Advisors's ResMed position peaked at $2.89M in Q2 2021.
  • 945 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.